Now is the time to get those cards you might have missed from the First Chapter and Floodborn, as well as some special packs.

The endorsement means the EMA will offer Carthera support and advice as it moves towards a regulatory filing for its ...

Following positive opinion, Carthera is one of the first companies to benefit from brand-new status – intended to support early access pathways for innovative devices targeting rare diseasesParis, ...

Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...